메뉴 건너뛰기




Volumn 18, Issue 4, 2013, Pages 1445-1459

The role of BRCA1 and BRCA2 in prostate cancer

Author keywords

Brca1; Brca2; Prostate cancer; Review; Sequence variants; Signaling pathways; Tumor suppressor

Indexed keywords


EID: 84880549520     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4191     Document Type: Article
Times cited : (15)

References (122)
  • 4
    • 0037445964 scopus 로고    scopus 로고
    • Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: A meta-analysis
    • DOI 10.1002/cncr.11262
    • M. P. Zeegers, A. Jellema and H. Ostrer: Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Cancer, 97(8), 1894-903 (2003). (Pubitemid 36397263)
    • (2003) Cancer , vol.97 , Issue.8 , pp. 1894-1903
    • Zeegers, M.P.A.1    Jellema, A.2    Ostrer, H.3
  • 6
    • 0038418411 scopus 로고    scopus 로고
    • Germ-line mutations of the macrophage scavenger receptor 1 gene: Association with prostate cancer risk in African-American men
    • D. C. Miller, S. L. Zheng, R. L. Dunn, A. V. Sarma, J. E. Montie, E. M. Lange, D. A. Meyers, J. Xu and K. A. Cooney: Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men. Cancer Res, 63(13), 3486-9 (2003). (Pubitemid 36793026)
    • (2003) Cancer Research , vol.63 , Issue.13 , pp. 3486-3489
    • Miller, D.C.1    Zheng, S.L.2    Dunn, R.L.3    Sarma, A.V.4    Montie, J.E.5    Lange, E.M.6    Meyers, D.A.7    Xu, J.8    Cooney, K.A.9
  • 7
    • 84858809529 scopus 로고    scopus 로고
    • Genetic variants associated with predisposition to prostate cancer and potential clinical implications
    • C. L. Goh, F. R. Schumacher, D. Easton, K. Muir, B. Henderson, Z. Kote-Jarai and R. A. Eeles: Genetic variants associated with predisposition to prostate cancer and potential clinical implications. J Intern Med, 271(4), 353-65 (2012).
    • (2012) J Intern Med , vol.271 , Issue.4 , pp. 353-365
    • Goh, C.L.1    Schumacher, F.R.2    Easton, D.3    Muir, K.4    Henderson, B.5    Kote-Jarai, Z.6    Eeles, R.A.7
  • 9
    • 1842612064 scopus 로고    scopus 로고
    • The complex genetic epidemiology of prostate cancer
    • Complex Diseases
    • D. J. Schaid: The complex genetic epidemiology of prostate cancer. Hum Mol Genet, 13 Spec No 1, R103- 21 (2004). (Pubitemid 38443804)
    • (2004) Human Molecular Genetics , vol.13 , Issue.1 REV. ISSUE
    • Schaid, D.J.1
  • 11
    • 0016273298 scopus 로고
    • Concerning a familial association between breast cancer and both prostatic and uterine malignancies
    • E. U. Thiessen: Concerning a familial association between breast cancer and both prostatic and uterine malignancies. Cancer, 34(4), 1102-7 (1974).
    • (1974) Cancer , vol.34 , Issue.4 , pp. 1102-1107
    • Thiessen, E.U.1
  • 12
    • 0026657958 scopus 로고
    • Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer
    • H. Tulinius, V. Egilsson, G. H. Olafsdottir and H. Sigvaldason: Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. BMJ, 305(6858), 855-7 (1992).
    • (1992) BMJ , vol.305 , Issue.6858 , pp. 855-857
    • Tulinius, H.1    Egilsson, V.2    Olafsdottir, G.H.3    Sigvaldason, H.4
  • 13
    • 0027258542 scopus 로고
    • Familial breast cancer risks: Effects of prostate and other cancers
    • D. E. Anderson and M. D. Badzioch: Familial breast cancer risks. Effects of prostate and other cancers. Cancer, 72(1), 114-9 (1993). (Pubitemid 23182059)
    • (1993) Cancer , vol.72 , Issue.1 , pp. 114-119
    • Anderson, D.E.1    Badzioch, M.D.2
  • 15
    • 0027494344 scopus 로고
    • Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer
    • A. Arason, R. B. Barkardottir and V. Egilsson: Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer. Am J Hum Genet, 52(4), 711-7 (1993). (Pubitemid 23310137)
    • (1993) American Journal of Human Genetics , vol.52 , Issue.4 , pp. 711-717
    • Arason, A.1    Barkardottir, R.B.2    Egilsson, V.3
  • 18
    • 0025613812 scopus 로고
    • Linkage of early-onset familial breast cancer to chromosome 17q21
    • J. M. Hall, M. K. Lee, B. Newman, J. E. Morrow, L. A. Anderson, B. Huey and M. C. King: Linkage of early-onset familial breast cancer to chromosome 17q21. Science, 250(4988), 1684-9 (1990). (Pubitemid 120031871)
    • (1990) Science , vol.250 , Issue.4988 , pp. 1684-1689
    • Hall, J.M.1    Lee, M.K.2    Newman, B.3    Morrow, J.E.4    Anderson, L.A.5    Huey, B.6    King, M.-C.7
  • 21
    • 0038743059 scopus 로고    scopus 로고
    • Regulation of BRCA1 expression and its relationship to sporadic breast cancer
    • DOI 10.1186/bcr557
    • C. R. Mueller and C. D. Roskelley: Regulation of BRCA1 expression and its relationship to sporadic breast cancer. Breast Cancer Res, 5(1), 45-52 (2003). (Pubitemid 36553579)
    • (2003) Breast Cancer Research , vol.5 , Issue.1 , pp. 45-52
    • Mueller, C.R.1    Roskelley, C.D.2
  • 24
    • 2642611983 scopus 로고    scopus 로고
    • Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers
    • DOI 10.1002/(SICI)1097-0215(19980703)77:1<1::AID-IJC1>3.0.CO;2-Y
    • H. Ozcelik, M. D. To, J. Couture, S. B. Bull and I. L. Andrulis: Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers. Int J Cancer, 77(1), 1-6 (1998). (Pubitemid 28308543)
    • (1998) International Journal of Cancer , vol.77 , Issue.1 , pp. 1-6
    • Ozcelik, H.1    To, M.D.T.2    Couture, J.3    Bull, S.B.4    Andrulis, I.L.5
  • 26
    • 0032542339 scopus 로고    scopus 로고
    • Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region
    • F. Magdinier, S. Ribieras, G. M. Lenoir, L. Frappart and R. Dante: Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region. Oncogene, 17(24), 3169-76 (1998). (Pubitemid 29020812)
    • (1998) Oncogene , vol.17 , Issue.24 , pp. 3169-3176
    • Magdinier, F.1    Ribieras, S.2    Lenoir, G.M.3    Frappart, L.4    Dante, R.5
  • 27
    • 0033580432 scopus 로고    scopus 로고
    • Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: Correlation with disease characteristics
    • A. Catteau, W. H. Harris, C. F. Xu and E. Solomon: Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene, 18(11), 1957-65 (1999). (Pubitemid 29150082)
    • (1999) Oncogene , vol.18 , Issue.11 , pp. 1957-1965
    • Catteau, A.1    Harris, W.H.2    Xu, C.-F.3    Solomon, E.4
  • 29
    • 0028330276 scopus 로고
    • Risks of cancer in BRCA1-mutation carriers
    • DOI 10.1016/S0140-6736(94)91578-4
    • D. Ford, D. F. Easton, D. T. Bishop, S. A. Narod and D. E. Goldgar: Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet, 343(8899), 692-5 (1994). (Pubitemid 24087847)
    • (1994) Lancet , vol.343 , Issue.8899 , pp. 692-695
    • Ford, D.1    Easton, D.F.2    Bishop, D.T.3    Narod, S.A.4    Goldgar, D.E.5
  • 31
    • 0035125062 scopus 로고    scopus 로고
    • Variation in cancer risks, by mutation position, in BRCA2 mutation carriers
    • DOI 10.1086/318181
    • D. Thompson and D. Easton: Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet, 68(2), 410-9 (2001). (Pubitemid 32147810)
    • (2001) American Journal of Human Genetics , vol.68 , Issue.2 , pp. 410-419
    • Thompson, D.1    Easton, D.2
  • 32
    • 0033523268 scopus 로고    scopus 로고
    • Cancer risks in BRCA2 mutation carriers. The breast cancer linkage consortium
    • Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst, 91(15), 1310-6 (1999).
    • (1999) J Natl Cancer Inst , vol.91 , Issue.15 , pp. 1310-1316
  • 35
    • 77954162660 scopus 로고    scopus 로고
    • Brca2 and trp53 deficiency cooperate in the progression of mouse prostate tumourigenesis
    • J. C. Francis, A. McCarthy, M. K. Thomsen, A. Ashworth and A. Swain: Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesis. PLoS Genet, 6(6), e1000995 (2010).
    • (2010) PLoS Genet , vol.6 , Issue.6
    • Francis, J.C.1    McCarthy, A.2    Thomsen, M.K.3    Ashworth, A.4    Swain, A.5
  • 38
    • 4544374528 scopus 로고    scopus 로고
    • BRCA1 and BRCA2: 1994 and beyond
    • DOI 10.1038/nrc1431
    • S. A. Narod and W. D. Foulkes: BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer, 4(9), 665-76 (2004). (Pubitemid 39215065)
    • (2004) Nature Reviews Cancer , vol.4 , Issue.9 , pp. 665-676
    • Narod, S.A.1    Foulkes, W.D.2
  • 40
    • 0031401511 scopus 로고    scopus 로고
    • Familial prostate cancer studies in utah
    • S. L. Neuhausen, M. H. Skolnick and L. Cannon-Albright: Familial prostate cancer studies in Utah. Br J Urol, 79 Suppl 1, 15-20 (1997).
    • (1997) Br J Urol , vol.79 , Issue.SUPPL. 1 , pp. 15-20
    • Neuhausen, S.L.1    Skolnick, M.H.2    Cannon-Albright, L.3
  • 42
    • 36448996703 scopus 로고    scopus 로고
    • Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
    • DOI 10.1038/nrc2054, PII NRC2054
    • J. D. Fackenthal and O. I. Olopade: Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer, 7(12), 937-48 (2007). (Pubitemid 350165853)
    • (2007) Nature Reviews Cancer , vol.7 , Issue.12 , pp. 937-948
    • Fackenthal, J.D.1    Olopade, O.I.2
  • 44
    • 0033358578 scopus 로고    scopus 로고
    • The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer [4]
    • DOI 10.1086/302525
    • A. Hubert, T. Peretz, O. Manor, L. Kaduri, N. Wienberg, I. Lerer, M. Sagi and D. Abeliovich: The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer. Am J Hum Genet, 65(3), 921- 4 (1999). (Pubitemid 30468737)
    • (1999) American Journal of Human Genetics , vol.65 , Issue.3 , pp. 921-924
    • Hubert, A.1    Peretz, T.2    Manor, O.3    Kaduri, L.4    Wienberg, N.5    Lerer, I.6    Sagi, M.7    Abeliovich, D.8
  • 45
    • 61349148781 scopus 로고    scopus 로고
    • Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations
    • I. Agalliu, R. Gern, S. Leanza and R. D. Burk: Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations. Clin Cancer Res, 15(3), 1112-20 (2009).
    • (2009) Clin Cancer Res , vol.15 , Issue.3 , pp. 1112-1120
    • Agalliu, I.1    Gern, R.2    Leanza, S.3    Burk, R.D.4
  • 46
    • 0031711516 scopus 로고    scopus 로고
    • Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer
    • S. Lehrer, F. Fodor, R. G. Stock, N. N. Stone, C. Eng, H. K. Song and M. McGovern: Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer. Br J Cancer, 78(6), 771-3 (1998). (Pubitemid 28418311)
    • (1998) British Journal of Cancer , vol.78 , Issue.6 , pp. 771-773
    • Lehrer, S.1    Fodor, F.2    Stock, R.G.3    Stone, N.N.4    Eng, C.5    Song, H.K.6    McGovern, M.7
  • 47
    • 0032764893 scopus 로고    scopus 로고
    • Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men
    • DOI 10.1002/(SICI)1097-0045(19990801)40:3 <172::AID-PROS5 >3.0.CO;2-R
    • K. L. Nastiuk, M. Mansukhani, M. B. Terry, P. Kularatne, M. A. Rubin, J. Melamed, M. D. Gammon, M. Ittmann and J. J. Krolewski: Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men. Prostate, 40(3), 172-7 (1999). (Pubitemid 29334865)
    • (1999) Prostate , vol.40 , Issue.3 , pp. 172-177
    • Nastiuk, K.L.1    Mansukhani, M.2    Terry, M.B.3    Kularatne, P.4    Rubin, M.A.5    Melamed, J.6    Gammon, M.D.7    Ittmann, M.8    Krolewski, J.J.9
  • 48
    • 0033152476 scopus 로고    scopus 로고
    • No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer
    • DOI 10.1002/(SICI)1097-0045(19990601)39:4<280::AID-PROS8>3.0.CO;2-F
    • E. P. Wilkens, D. Freije, J. Xu, D. R. Nusskern, H. Suzuki, S. D. Isaacs, K. Wiley, P. Bujnovsky, D. A. Meyers, P. C. Walsh and W. B. Isaacs: No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer. Prostate, 39(4), 280-4 (1999). (Pubitemid 29244502)
    • (1999) Prostate , vol.39 , Issue.4 , pp. 280-284
    • Wilkens, E.P.1    Freije, D.2    Xu, J.3    Nusskern, D.R.4    Suzuki, H.5    Isaacs, S.D.6    Wiley, K.7    Bujnovszky, P.8    Meyers, D.A.9    Walsh, P.C.10    Isaacs, W.B.11
  • 59
    • 0036381338 scopus 로고    scopus 로고
    • Analysis of brca1 and brca2 in breast and breast/ovarian cancer families shows population substructure in the iberian peninsula
    • A. Vega, M. Torres, J. I. Martinez, C. Ruiz-Ponte, F. Barros and A. Carracedo: Analysis of BRCA1 and BRCA2 in breast and breast/ovarian cancer families shows population substructure in the Iberian peninsula. Ann Hum Genet, 66(Pt 1), 29-36 (2002).
    • (2002) Ann Hum Genet , vol.66 , Issue.PART 1 , pp. 29-36
    • Vega, A.1    Torres, M.2    Martinez, J.I.3    Ruiz-Ponte, C.4    Barros, F.5    Carracedo, A.6
  • 73
    • 0034162984 scopus 로고    scopus 로고
    • BRCA1 and BRCA2 have a limited role in familial prostate cancer
    • C. S. Sinclair, R. Berry, D. Schaid, S. N. Thibodeau and F. J. Couch: BRCA1 and BRCA2 have a limited role in familial prostate cancer. Cancer Res, 60(5), 1371-5 (2000). (Pubitemid 30152009)
    • (2000) Cancer Research , vol.60 , Issue.5 , pp. 1371-1375
    • Sinclair, C.S.1    Berry, R.2    Schaid, D.3    Thibodeau, S.N.4    Couch, F.J.5
  • 74
    • 4644363085 scopus 로고    scopus 로고
    • Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers
    • DOI 10.1158/1078-0432.CCR-04-0554
    • K. A. Zuhlke, J. J. Madeoy, J. Beebe-Dimmer, K. A. White, A. Griffin, E. M. Lange, S. B. Gruber, E. A. Ostrander and K. A. Cooney: Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers. Clin Cancer Res, 10(18 Pt 1), 5975-80 (2004). (Pubitemid 39287501)
    • (2004) Clinical Cancer Research , vol.10 , Issue.I18 , pp. 5975-5980
    • Zuhlke, K.A.1    Madeoy, J.J.2    Beebe-Dimmer, J.3    White, K.A.4    Griffin, A.5    Lange, E.M.6    Gruber, S.B.7    Ostrander, E.A.8    Cooney, K.A.9
  • 78
    • 0032507879 scopus 로고    scopus 로고
    • BRCA1 as a potential human prostate tumor suppressor: Modulation of proliferation, damage responses and expression of cell regulatory proteins
    • S. Fan, J. A. Wang, R. Q. Yuan, Y. X. Ma, Q. Meng, M. R. Erdos, L. C. Brody, I. D. Goldberg and E. M. Rosen: BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins. Oncogene, 16(23), 3069-82 (1998). (Pubitemid 28297729)
    • (1998) Oncogene , vol.16 , Issue.23 , pp. 3069-3082
    • Fan, S.1    Wang, J.-A.2    Yuan, R.-Q.3    Ma, Y.X.4    Meng, Q.5    Erdos, M.R.6    Brody, L.C.7    Goldberg, I.D.8    Rosen, E.M.9
  • 81
    • 63449121864 scopus 로고    scopus 로고
    • Tumor suppressor brca1 is expressed in prostate cancer and controls insulin-like growth factor i receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner
    • H. Schayek, K. Haugk, S. Sun, L. D. True, S. R. Plymate and H. Werner: Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner. Clin Cancer Res, 15(5), 1558-65 (2009).
    • (2009) Clin Cancer Res , vol.15 , Issue.5 , pp. 1558-1565
    • Schayek, H.1    Haugk, K.2    Sun, S.3    True, L.D.4    Plymate, S.R.5    Werner, H.6
  • 84
    • 0033660593 scopus 로고    scopus 로고
    • Estrogen receptormediated processes in normal and cancer cells
    • R. B. Dickson and G. M. Stancel: Estrogen receptormediated processes in normal and cancer cells. J Natl Cancer Inst Monogr(27), 135-45 (2000).
    • (2000) J Natl Cancer Inst Monogr , Issue.27 , pp. 135-145
    • Dickson, R.B.1    Stancel, G.M.2
  • 86
    • 0036755404 scopus 로고    scopus 로고
    • Androgen receptor as a target in androgenindependent prostate cancer
    • discussion 138-9
    • S. P. Balk: Androgen receptor as a target in androgenindependent prostate cancer. Urology, 60(3 Suppl 1), 132- 8; discussion 138-9 (2002).
    • (2002) Urology , vol.60 , Issue.3 SUPPL. 1 , pp. 132-138
    • Balk, S.P.1
  • 88
    • 0034633661 scopus 로고    scopus 로고
    • Increase of androgeninduced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells
    • S. Yeh, Y. C. Hu, M. Rahman, H. K. Lin, C. L. Hsu, H. J. Ting, H. Y. Kang and C. Chang: Increase of androgeninduced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells. Proc Natl Acad Sci U S A, 97(21), 11256-61 (2000).
    • (2000) Proc Natl Acad Sci USA , vol.97 , Issue.21 , pp. 11256-11261
    • Yeh, S.1    Hu, Y.C.2    Rahman, M.3    Lin, H.K.4    Hsu, C.L.5    Ting, H.J.6    Kang, H.Y.7    Chang, C.8
  • 90
    • 0035910507 scopus 로고    scopus 로고
    • Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells
    • DOI 10.1016/S0014-5793(00)02430-3, PII S0014579300024303
    • B. Gao, X. Shen, G. Kunos, Q. Meng, I. D. Goldberg, E. M. Rosen and S. Fan: Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells. FEBS Lett, 488(3), 179-84 (2001). (Pubitemid 32103593)
    • (2001) FEBS Letters , vol.488 , Issue.3 , pp. 179-184
    • Gao, B.1    Shen, X.2    Kunos, G.3    Meng, Q.4    Goldberg, I.D.5    Rosen, E.M.6    Fan, S.7
  • 92
    • 84864106481 scopus 로고    scopus 로고
    • Dynamic coregulatory complex containing BRCA1, e2f1 and ctip controls ATM transcription
    • C. Moiola, P. De Luca, J. Cotignola, K. Gardner, E. Vazquez and A. De Siervi: Dynamic coregulatory complex containing BRCA1, E2F1 and CtIP controls ATM transcription. Cell Physiol Biochem, 30(3), 596-608 (2012).
    • (2012) Cell Physiol Biochem , vol.30 , Issue.3 , pp. 596-608
    • Moiola, C.1    De Luca, P.2    Cotignola, J.3    Gardner, K.4    Vazquez, E.5    De Siervi, A.6
  • 93
    • 66149158200 scopus 로고    scopus 로고
    • PKCalpha activation downregulates atm and radio-sensitizes androgen-sensitive human prostate cancer cells in vitro and in vivo
    • J. P. Truman, S. A. Rotenberg, J. H. Kang, G. Lerman, Z. Fuks, R. Kolesnick, V. E. Marquez and A. Haimovitz- Friedman: PKCalpha activation downregulates ATM and radio-sensitizes androgen-sensitive human prostate cancer cells in vitro and in vivo. Cancer Biol Ther, 8(1), 54-63 (2009).
    • (2009) Cancer Biol Ther , vol.8 , Issue.1 , pp. 54-63
    • Truman, J.P.1    Rotenberg, S.A.2    Kang, J.H.3    Lerman, G.4    Fuks, Z.5    Kolesnick, R.6    Marquez, V.E.7    Friedman A.H.-8
  • 94
    • 0029826841 scopus 로고    scopus 로고
    • Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin- like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium
    • DOI 10.1210/jc.81.10.3774
    • M. K. Tennant, J. B. Thrasher, P. A. Twomey, R. H. Drivdahl, R. S. Birnbaum and S. R. Plymate: Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium. J Clin Endocrinol Metab, 81(10), 3774-82 (1996). (Pubitemid 26339953)
    • (1996) Journal of Clinical Endocrinology and Metabolism , vol.81 , Issue.10 , pp. 3774-3782
    • Tennant, M.K.1    Thrasher, J.B.2    Twomey, P.A.3    Drivdahl, R.H.4    Birnbaum, R.S.5    Plymate, S.R.6
  • 95
    • 33748927940 scopus 로고    scopus 로고
    • Interaction of IGF signaling and the androgen receptor in prostate cancer progression
    • DOI 10.1002/jcb.20929
    • J. D. Wu, K. Haugk, L. Woodke, P. Nelson, I. Coleman and S. R. Plymate: Interaction of IGF signaling and the androgen receptor in prostate cancer progression. J Cell Biochem, 99(2), 392-401 (2006). (Pubitemid 44435557)
    • (2006) Journal of Cellular Biochemistry , vol.99 , Issue.2 , pp. 392-401
    • Wu, J.D.1    Haugk, K.2    Woodke, L.3    Nelson, P.4    Coleman, I.5    Plymate, S.R.6
  • 96
    • 64249111139 scopus 로고    scopus 로고
    • Circulating insulin-like growth factor peptides and prostate cancer risk: A systematic review and meta-analysis
    • M. A. Rowlands, D. Gunnell, R. Harris, L. J. Vatten, J. M. Holly and R. M. Martin: Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer, 124(10), 2416-29 (2009).
    • (2009) Int J Cancer , vol.124 , Issue.10 , pp. 2416-2429
    • Rowlands, M.A.1    Gunnell, D.2    Harris, R.3    Vatten, L.J.4    Holly, J.M.5    Martin, R.M.6
  • 97
    • 0032559272 scopus 로고    scopus 로고
    • Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
    • DOI 10.1126/science.279.5350.563
    • J. M. Chan, M. J. Stampfer, E. Giovannucci, P. H. Gann, J. Ma, P. Wilkinson, C. H. Hennekens and M. Pollak: Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science, 279(5350), 563-6 (1998). (Pubitemid 28067285)
    • (1998) Science , vol.279 , Issue.5350 , pp. 563-566
    • Chan, J.M.1    Stampfer, M.J.2    Giovannucci, E.3    Gann, P.H.4    Ma, J.5    Wilkinson, P.6    Hennekens, C.H.7    Pollak, M.8
  • 98
    • 0035881876 scopus 로고    scopus 로고
    • In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR)
    • T. Nickerson, F. Chang, D. Lorimer, S. P. Smeekens, C. L. Sawyers and M. Pollak: In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR). Cancer Res, 61(16), 6276-80 (2001). (Pubitemid 32762567)
    • (2001) Cancer Research , vol.61 , Issue.16 , pp. 6276-6280
    • Nickerson, T.1    Chang, F.2    Lorimer, D.3    Smeekens, S.P.4    Sawyers, C.L.5    Pollak, M.6
  • 99
    • 0034033970 scopus 로고    scopus 로고
    • BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: Potential interaction between BRCA1 and Sp1
    • DOI 10.1006/mgme.1999.2958
    • S. B. Maor, S. Abramovitch, M. R. Erdos, L. C. Brody and H. Werner: BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: potential interaction between BRCA1 and Sp1. Mol Genet Metab, 69(2), 130-6 (2000). (Pubitemid 30180697)
    • (2000) Molecular Genetics and Metabolism , vol.69 , Issue.2 , pp. 130-136
    • Maor, S.B.1    Abramovitch, S.2    Erdos, M.R.3    Brody, L.C.4    Werner, H.5
  • 100
    • 0036847690 scopus 로고    scopus 로고
    • Elevated Skp2 protein expression in human prostate cancer: Association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival
    • G. Yang, G. Ayala, A. De Marzo, W. Tian, A. Frolov, T. M. Wheeler, T. C. Thompson and J. W. Harper: Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. Clin Cancer Res, 8(11), 3419-26 (2002). (Pubitemid 35340716)
    • (2002) Clinical Cancer Research , vol.8 , Issue.11 , pp. 3419-3426
    • Yang, G.1    Ayala, G.2    De Marzo, A.3    Tian, W.4    Frolov, A.5    Wheeler, T.M.6    Thompson, T.C.7    Harper, J.W.8
  • 102
  • 103
    • 33746837658 scopus 로고    scopus 로고
    • Up-regulation of Skp2 after prostate cancer cell adhesion to basement membranes results in BRCA2 degradation and cell proliferation
    • DOI 10.1074/jbc.M604636200
    • L. Moro, A. A. Arbini, E. Marra and M. Greco: Upregulation of Skp2 after prostate cancer cell adhesion to basement membranes results in BRCA2 degradation and cell proliferation. J Biol Chem, 281(31), 22100-7 (2006). (Pubitemid 44181914)
    • (2006) Journal of Biological Chemistry , vol.281 , Issue.31 , pp. 22100-22107
    • Moro, L.1    Arbini, A.A.2    Marra, E.3    Greco, M.4
  • 104
    • 4344717012 scopus 로고    scopus 로고
    • BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage
    • DOI 10.1128/MCB.24.17.7444-7455.2004
    • A. R. Schoenfeld, S. Apgar, G. Dolios, R. Wang and S. A. Aaronson: BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage. Mol Cell Biol, 24(17), 7444-55 (2004). (Pubitemid 39121473)
    • (2004) Molecular and Cellular Biology , vol.24 , Issue.17 , pp. 7444-7455
    • Schoenfeld, A.R.1    Apgar, S.2    Dolios, G.3    Wang, R.4    Aaronson, S.A.5
  • 105
    • 0032126029 scopus 로고    scopus 로고
    • Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells
    • D. W. Abbott, M. L. Freeman and J. T. Holt: Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells. J Natl Cancer Inst, 90(13), 978-85 (1998). (Pubitemid 28340438)
    • (1998) Journal of the National Cancer Institute , vol.90 , Issue.13 , pp. 978-985
    • Abbott, D.W.1    Freeman, M.L.2    Holt, J.T.3
  • 106
    • 0020601626 scopus 로고
    • Loss of basement membrane components by invasive tumors but not by their benign counterparts
    • S. H. Barsky, G. P. Siegal, F. Jannotta and L. A. Liotta: Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest, 49(2), 140-7 (1983). (Pubitemid 13039938)
    • (1983) Laboratory Investigation , vol.49 , Issue.2 , pp. 140-147
    • Barsky, S.H.1    Siegal, G.P.2    Jannotta, F.3    Liotta, L.A.4
  • 107
    • 5044238876 scopus 로고    scopus 로고
    • Integrin signalling during tumour progression
    • DOI 10.1038/nrm1490
    • W. Guo and F. G. Giancotti: Integrin signalling during tumour progression. Nat Rev Mol Cell Biol, 5(10), 816-26 (2004). (Pubitemid 39336275)
    • (2004) Nature Reviews Molecular Cell Biology , vol.5 , Issue.10 , pp. 816-826
    • Guo, W.1    Giancotti, F.G.2
  • 108
    • 0030033379 scopus 로고    scopus 로고
    • Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the 1 integrin
    • DOI 10.1007/BF00157682
    • P. J. Kostenuik, O. Sanchez-Sweatman, F. W. Orr and G. Singh: Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the alpha 2 beta 1 integrin. Clin Exp Metastasis, 14(1), 19-26 (1996). (Pubitemid 26008958)
    • (1996) Clinical and Experimental Metastasis , vol.14 , Issue.1 , pp. 19-26
    • Kostenuik, P.J.1    Sanchez-Sweatman, O.2    William Orr, F.3    Singh, G.4
  • 109
    • 0025301851 scopus 로고
    • The cellular basis of site-specific tumor metastasis
    • B. R. Zetter: The cellular basis of site-specific tumor metastasis. N Engl J Med, 322(9), 605-12 (1990). (Pubitemid 20190796)
    • (1990) New England Journal of Medicine , vol.322 , Issue.9 , pp. 605-612
    • Zetter, B.R.1
  • 110
    • 20444490365 scopus 로고    scopus 로고
    • Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation
    • DOI 10.1074/jbc.M414091200
    • L. Moro, A. A. Arbini, E. Marra and M. Greco: Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation. J Biol Chem, 280(23), 22482-91 (2005). (Pubitemid 40827904)
    • (2005) Journal of Biological Chemistry , vol.280 , Issue.23 , pp. 22482-22491
    • Moro, L.1    Arbini, A.A.2    Marra, E.3    Greco, M.4
  • 111
    • 36048936602 scopus 로고    scopus 로고
    • Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2
    • L. Moro, A. A. Arbini, E. Marra and M. Greco: Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2. Int J Oncol, 30(1), 217-24 (2007).
    • (2007) Int J Oncol , vol.30 , Issue.1 , pp. 217-224
    • Moro, L.1    Arbini, A.A.2    Marra, E.3    Greco, M.4
  • 112
    • 38949084511 scopus 로고    scopus 로고
    • Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9
    • DOI 10.1111/j.1349-7006.2007.00719.x
    • L. Moro, A. A. Arbini, J. L. Yao, P. A. di Sant'Agnese, E. Marra and M. Greco: Loss of BRCA2 promotes prostate cancer cell invasion through upregulation of matrix metalloproteinase-9. Cancer Sci, 99(3), 553-63 (2008). (Pubitemid 351228573)
    • (2008) Cancer Science , vol.29 , Issue.3 , pp. 553-563
    • Moro, L.1    Arbini, A.A.2    Yao, J.L.3    Di Sant'Agnese, P.A.4    Marra, E.5    Greco, M.6
  • 113
    • 0033564523 scopus 로고    scopus 로고
    • Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells
    • DOI 10.1002/(SICI)1097-0045(19990615)40:1<37::AID-PROS5>3.0.CO;2-P
    • R. Yuan, S. Fan, J. A. Wang, Q. Meng, Y. Ma, D. Schreiber, I. D. Goldberg and E. M. Rosen: Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells. Prostate, 40(1), 37-49 (1999). (Pubitemid 29244493)
    • (1999) Prostate , vol.40 , Issue.1 , pp. 37-49
    • Yuan, R.1    Fan, S.2    Wang, J.-A.3    Meng, Q.4    Ma, Y.5    Schreiber, D.6    Goldberg, I.D.7    Rosen, E.M.8
  • 114
    • 0034687341 scopus 로고    scopus 로고
    • The anti-proliferative effects of 1alpha, 25(OH)2d3 on breast and prostate cancer cells are associated with induction of brca1 gene expression
    • M. J. Campbell, A. F. Gombart, S. H. Kwok, S. Park and H. P. Koeffler: The anti-proliferative effects of 1alpha, 25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression. Oncogene, 19(44), 5091-7 (2000).
    • (2000) Oncogene , vol.19 , Issue.44 , pp. 5091-5097
    • Campbell, M.J.1    Gombart, A.F.2    Kwok, S.H.3    Park, S.4    Koeffler, H.P.5
  • 115
    • 32544442522 scopus 로고    scopus 로고
    • BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells
    • DOI 10.1038/sj.bjc.6602935, PII 6602935
    • S. Fan, Q. Meng, K. Auborn, T. Carter and E. M. Rosen: BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer, 94(3), 407-26 (2006) doi:10.1038/sj.bjc.6602935. (Pubitemid 43237565)
    • (2006) British Journal of Cancer , vol.94 , Issue.3 , pp. 407-426
    • Fan, S.1    Meng, Q.2    Auborn, K.3    Carter, T.4    Rosen, E.M.5
  • 116
    • 1442307845 scopus 로고    scopus 로고
    • Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: A review of the literature
    • DOI 10.1200/JCO.2004.05.055
    • A. Liede, B. Y. Karlan and S. A. Narod: Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol, 22(4), 735-42 (2004). (Pubitemid 41095079)
    • (2004) Journal of Clinical Oncology , vol.22 , Issue.4 , pp. 735-742
    • Liede, A.1    Karlan, B.Y.2    Narod, S.A.3
  • 117
    • 80051813565 scopus 로고    scopus 로고
    • A risk prediction algorithm based on family history and common genetic variants: Application to prostate cancer with potential clinical impact
    • R. J. Macinnis, A. C. Antoniou, R. A. Eeles, G. Severi, A. A. Al Olama, L. McGuffog, Z. Kote-Jarai, M. Guy, L. T. O'Brien, A. L. Hall, R. A. Wilkinson, E. Sawyer, A. T. Ardern-Jones, D. P. Dearnaley, A. Horwich, V. S. Khoo, C. C. Parker, R. A. Huddart, N. Van As, M. R. McCredie, D. R. English, G. G. Giles, J. L. Hopper and D. F. Easton: A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact. Genet Epidemiol, 35(6), 549-56 (2011).
    • (2011) Genet Epidemiol , vol.35 , Issue.6 , pp. 549-556
    • MacInnis, R.J.1    Antoniou, A.C.2    Eeles, R.A.3    Severi, G.4    Olama, A.A.A.5    McGuffog6
  • 120
    • 2542496143 scopus 로고    scopus 로고
    • Founder mutations in BRCA1/2 are not frequent in canadian ashkenazi jewish men with prostate cancer
    • N. Hamel, K. Kotar and W. D. Foulkes: Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer. BMC Med Genet, 4, 7 (2003).
    • (2003) BMC Med Genet , vol.4 , pp. 7
    • Hamel, N.1    Kotar, K.2    Foulkes, W.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.